Ticker Details
Harmony Biosciences Holdings, Inc.
IPO Date:	August 19, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$1.99B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.87 | 2.38%
Avg Daily Range (30 D):	$0.95 | 3.07%
Avg Daily Range (90 D):	$0.72 | 2.31%

Institutional Daily Volume
Avg Daily Volume:	.45M
Avg Daily Volume (30 D):	.64M
Avg Daily Volume (90 D):	.74M

Trade Size
Avg Trade Size (Sh.):	52
Avg Trade Size (Sh.) (30 D):	50
Avg Trade Size (Sh.) (90 D):	52

Institutional Trades
Total Institutional Trades:	2,230
Avg Institutional Trade:	$2.38M
Avg Institutional Trade (30 D):	$2.53M
Avg Institutional Trade (90 D):	$2.64M
Avg Institutional Trade Volume:	.07M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$3.03M
Avg Closing Trade (30 D):	$3.71M
Avg Closing Trade (90 D):	$3.68M
Avg Closing Volume:	85.41K

News

May 19, 2026 @ 9:33 PM A beaten-down biotech just lost a meaningful backe... Source: Seena Hassouna

Apr 16, 2026 @ 5:21 PM 12 Small-Cap Stocks Primed for Breakouts as Earnin... Source: David Wagner

Feb 1, 2026 @ 3:19 AM Harmony Biosciences' CFO Sells All of Her Insider ... Source: Adé Hennis

Jan 27, 2026 @ 5:02 PM Harmony Biosciences' Sales and Profits Have Soared... Source: Dan Caplinger

Apr 8, 2025 @ 5:00 PM Developmental and Epileptic Encephalopathies Marke... Source: Delveinsight

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$2.53	$.56	$.4
Diluted EPS	$2.49	$.55	$.39
Revenue	$899.11M	$215.39M	$243.78M
Gross Profit	$688.25M	$170.88M	$175.23M
Net Income / Loss	$145.62M	$32.49M	$22.49M
Operating Income / Loss	$189.52M	$37.29M	$38.56M
Cost of Revenue	$210.86M	$44.51M	$68.55M
Net Cash Flow	$100.4M	$-163.1M	$105.5M
PE Ratio